RayPlex® Bead Array Uncovers a Chemokine Signature of Viral Co-Infection in Pediatric Pneumonia
At a Glance
A research team at Henan Children's Hospital and Zhengzhou University set out to explain why children with Mycoplasma pneumoniae pneumonia (MPP) become more severely ill when they are also infected with a respiratory virus such as adenovirus (ADV) or influenza A virus (IAV). Working from small, precious BALF samples, they applied a multi-omic approach to decipher differences between singular infection and co-infection. For proteomic measurement of the host immune response, they used the RayPlex® Human Cytokine Storm Array and quantified 25 cytokines, chemokines, and growth factors in a single panel.
The array revealed a striking result: among children co-infected with ADV, every CCL-family chemokine in the panel (CCL2, CCL3, CCL4, CCL5, and CCL11) and PDGF-BB were significantly elevated relative to single Mycoplasma pneumoniae infection. This chemokine signature pointed to polarization of monocytes towards an M1 phenotype as a mechanism of disease exacerbation.
The Challenge
Respiratory viral co-infection is common in pediatric MPP and is associated with longer hospital stays, pulmonary necrosis, and extrapulmonary complications. Yet the immune mechanisms behind this worsening disease course are unclear. BALF is the most clinically relevant sample for studying airway immunity, but it comes with constraints:
- Limited volume: Only 5–10 mL of BALF was collected per child, with portions reserved in parallel for untargeted metabolomics and 16S microbiome sequencing.
- Irreplaceable samples: Flexible bronchoscopy in pediatric patients cannot simply be repeated to generate more material.
